title: Estrogen and progestogen therapy in postmenopausal women.
abstract: This Educational Bulletin discusses the effectiveness of hormone therapy (HT) for relieving vasomotor and urogenital symptoms and the side effects associated with such treatment; considers the evidence concerning the effects of HT on the risk of osteoporosis and related fractures and on the risks of coronary artery disease, dementia, and colorectal cancer; and considers the longer term effects of HT on the risks of stroke, venous thromboembolism, and cancer of the breast, endometrium, and ovary.
mesh_terms: D000544:Alzheimer Disease / Q000517:prevention & control; D002986:Clinical Trials as Topic; D003072:Cognition Disorders / Q000517:prevention & control; D003327:Coronary Disease / Q000517:prevention & control; D016021:Epidemiologic Studies; D004967:Estrogens / Q000009:adverse effects / Q000172:deficiency / Q000627:therapeutic use*; D005260:Female; D052776:Female Urogenital Diseases / Q000175:diagnosis / Q000188:drug therapy; D005833:Genital Neoplasms, Female / Q000139:chemically induced / Q000453:epidemiology; D020249:Hormone Replacement Therapy / Q000009:adverse effects / Q000379:methods; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control; D017698:Postmenopause / Q000187:drug effects*; D011372:Progestins / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome; D014652:Vascular Diseases / Q000175:diagnosis / Q000188:drug therapy
chemical_list: D004967:Estrogens; D011372:Progestins